Sterna Sitting Pretty As Inflammatory Pipeline Shows Promise
Executive Summary
In an interview with Scrip, Sterna Biologicals CEO Christian Pangratz says that the small German company has a number of options available to advance its Phase II projects in asthma, COPD, ulcerative colitis and atopic dermatitis.